Aesthetic Device Clearance Tracker: FDA-Cleared Energy Devices

Most aesthetic energy devices clear via 510(k) (substantial equivalence to a predicate device), a faster pathway that requires demonstration of safety and effectiveness for a specific intended use. A 510(k) clearance is not a blanket approval for all uses of that technology—it covers only the indications, parameters, and patient populations tested and documented in the submission.

PMA (Premarket Approval) is the gold standard, requiring clinical trial data and FDA review of the full risk-benefit profile; fewer aesthetic devices pursue PMA because the timeline and cost are higher, but PMA clearance carries broader regulatory confidence.

When a rep claims a device is "cleared for" something, ask for the K-number (510(k)) or PMA number and request the actual FDA summary. The 510(k) summary, publicly available on the FDA's CDRH database, lists the specific intended use, patient population, and operating parameters. If the rep's claim falls outside that scope, the device is being used off-label—which may be legal in some contexts but is not FDA-cleared for that use. Always verify before marketing or billing a treatment as "FDA-cleared."

Monopolar and bipolar RF devices (e.g., Thermage, Exilis) typically clear for skin tightening and wrinkle reduction via 510(k) predicate pathways. Clearance usually specifies depth of penetration (dermis vs. subcutaneous), target tissue, and anatomical zones (face, neck, body). Some are cleared for cellulite reduction; others are not. Depth and energy parameters matter: a device cleared for 2.65 mm penetration is not cleared for deeper subcutaneous work without additional data.

Microneedling-RF hybrids (e.g., Infini, Secret RF) combine mechanical needling with radiofrequency energy. FDA clearance for these typically covers fractional skin resurfacing, wrinkle reduction, and scar improvement. The cleared depth depends on needle length and RF power; a device cleared for 0.5 mm needles is not cleared for 2.0 mm needles without separate validation. Verify the exact needle depth, RF wattage, and treatment zone in the 510(k) summary. Cytrellis' ellacor (micro-coring technology) represents a newer category; confirm its specific FDA clearance status and cleared indications before adoption.

Ablative lasers (CO₂, erbium) clear for skin resurfacing, scar revision, and wart/lesion removal; clearance specifies wavelength, pulse duration, and depth of ablation. Non-ablative lasers and intense pulsed light (IPL) typically clear for hair removal, vascular lesions, and pigmented lesions; some have expanded indications for collagen remodeling and wrinkle reduction.

Critical detail: a laser cleared for hair removal is not automatically cleared for vascular lesions or pigmented lesions, even if the wavelength overlaps. Each indication requires separate 510(k) or PMA clearance. Wavelength, pulse width, fluence (energy density), and spot size all affect the cleared use; changing any parameter without FDA clearance can shift the device into off-label territory.

Ultherapy PRIME (Merz, ultrasound-based) recently expanded its FDA clearance to include knee skin lifting, demonstrating how indications can expand over time. Always check the FDA's device database for the most recent clearance amendment or supplemental application (sBLA) for your device, as new indications are regularly added.

Focused ultrasound (e.g., Ultherapy) clears via 510(k) for non-invasive skin lifting and tightening by inducing collagen remodeling at specific depths. Clearance specifies the target depth (e.g., SMAS layer for face, dermis for body), frequency (MHz), and anatomical zones. Ultherapy PRIME's recent knee indication expansion shows that ultrasound devices can gain new cleared uses; however, each anatomical site and depth requires separate validation.

Key distinction: real-time visualization (as in Ultherapy PRIME) is a cleared feature that differentiates it from non-visualized ultrasound systems. If you purchase a device marketed as having real-time visualization, confirm that feature is included in the FDA clearance; some vendors may retrofit or claim visualization capability that was not part of the original 510(k) submission.

Ultrasound depth penetration and frequency directly affect safety and efficacy; a device cleared for 4.5 MHz at 1.5 mm depth is not cleared for 7 MHz or 3.0 mm depth without additional testing. Verify the exact frequency and depth parameters in your device's 510(k) summary.

Step 1: Ask the rep for the K-number or PMA number. If they cannot provide it, the device may not be FDA-cleared, or the rep does not understand the product's regulatory status.

Step 2: Search the FDA's CDRH database (fda.gov/medical-devices) using the device name or K-number. Download the 510(k) summary or PMA approval letter.

Step 3: Cross-check the rep's claims against the "Intended Use" section. If the rep claims the device is cleared for cellulite, scar revision, or a specific anatomical site not mentioned in the summary, that use is off-label.

Step 4: Note the predicate device. A 510(k) clears a device as substantially equivalent to a named predicate. If the predicate is old or from a different manufacturer, ask why that predicate was chosen and whether newer predicates exist.

Step 5: Check for supplemental applications (sBLAs). Devices often gain new indications after initial clearance. Search the FDA database for amendments or supplements to the original K-number.

Red flags: Vague language ("skin rejuvenation," "anti-aging"), claims of off-label uses presented as cleared, inability to cite the K-number, or marketing materials that contradict the FDA summary.

FDA clearance is federal; state boards set scope-of-practice rules. A device cleared by FDA for a treatment may still be outside the scope of practice for a nurse injector, aesthetician, or physician assistant in your state, depending on supervision requirements and delegation rules.

Example: RF microneedling may be FDA-cleared for scar revision, but your state's medical board may require physician supervision or prohibit delegation to non-physician providers for that indication. Conversely, some states allow nurse injectors to operate cleared devices independently under standing orders.

Always verify with your state medical board, nursing board, or aesthetic licensing authority before purchasing or deploying a device. Regulatory landscape varies significantly by state; what is permitted in California may be prohibited in Texas. Document your compliance review in writing and retain it in your regulatory file. If you operate across multiple states, map the scope-of-practice rules for each jurisdiction and ensure your device protocols align. Failure to do so can result in board discipline, license suspension, or civil liability—far costlier than the device itself.